Overview

Prevention of Catheter-Associated Urinary Tract Infection in Incontinence and Reconstructive Pelvic Surgery Patients

Status:
Terminated

Trial end date:
2013-08-01

Target enrollment:
0

Participant gender:
Female

Summary

The study will assess the risk of catheter associated urinary tract infection in women undergoing incontinence or reconstructive pelvic surgery. Women will be given an antibiotic or placebo at the time of catheter removal. The investigators hypothesize that prophylactic antibiotics will reduce the rate of infection.

Phase:

N/A

Accepts Healthy Volunteers?

Accepts Healthy Volunteers

Details

Lead Sponsor:

The Cleveland Clinic

Collaborator:

American Urogynecologic Society

Treatments:

Trimethoprim, Sulfamethoxazole Drug Combination

Criteria

Inclusion Criteria:

- Requires catheterization >24h hours following incontinence or pelvic reconstructive
surgery

Exclusion Criteria:

- Receipt of antibiotics for either prophylaxis or treatment of a known infection during
the postoperative hospitalization

- Allergy to sulfonamides or trimethoprim

- Non-English speaking

- Pregnancy

- Breast feeding

- Severe renal impairment (creatinine clearance <30)

- Patients taking dofetilide, methenamine, procaine, warfarin, procainamide,
methotrexate.